California State Teachers Retirement System (CalSTRS)’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.55M | Buy |
142,561
+43,257
| +44% | +$540K | ﹤0.01% | 1660 |
|
|
2025
Q4 | $1.28M | Sell |
99,304
-4,892
| -5% | -$62.8K | ﹤0.01% | 1675 |
|
|
2025
Q3 | $1.35M | Buy |
104,196
+9,241
| +10% | +$123K | ﹤0.01% | 1638 |
|
|
2025
Q2 | $1.69M | Buy |
94,955
+812
| +0.9% | +$14.2K | ﹤0.01% | 1454 |
|
|
2025
Q1 | $1.68M | Sell |
94,143
-2,246
| -2% | -$51K | ﹤0.01% | 1427 |
|
|
2024
Q4 | $2.87M | Sell |
96,389
-635
| -0.7% | -$13.4K | ﹤0.01% | 1184 |
|
|
2024
Q3 | $1.52M | Sell |
97,024
-2,582
| -3% | -$46.8K | ﹤0.01% | 1553 |
|
|
2024
Q2 | $1.71M | Sell |
99,606
-2,352
| -2% | -$41.4K | ﹤0.01% | 1472 |
|
|
2024
Q1 | $1.59M | Sell |
101,958
-5,686
| -5% | -$83.6K | ﹤0.01% | 1551 |
|
|
2023
Q4 | $1.61M | Sell |
107,644
-4,935
| -4% | -$66K | ﹤0.01% | 1575 |
|
|
2023
Q3 | $1.82M | Sell |
112,579
-44,719
| -28% | -$1.29M | ﹤0.01% | 1446 |
|
|
2023
Q2 | $6.53M | Sell |
157,298
-4,024
| -2% | -$250K | 0.01% | 818 |
|
|
2023
Q1 | $9.7M | Sell |
161,322
-1,537
| -0.9% | -$123K | 0.01% | 656 |
|
|
2022
Q4 | $11.9M | Buy |
162,859
+2,877
| +2% | +$216K | 0.02% | 599 |
|
|
2022
Q3 | $12.2M | Sell |
159,982
-1,751
| -1% | -$137K | 0.02% | 580 |
|
|
2022
Q2 | $11.2M | Buy |
161,733
+1,048
| +0.7% | +$78.9K | 0.02% | 611 |
|
|
2022
Q1 | $13.3M | Sell |
160,685
-10,176
| -6% | -$750K | 0.02% | 620 |
|
|
2021
Q4 | $12.8M | Sell |
170,861
-773
| -0.5% | -$77.6K | 0.02% | 676 |
|
|
2021
Q3 | $19.9M | Sell |
171,634
-12,657
| -7% | -$1.91M | 0.03% | 549 |
|
|
2021
Q2 | $40.9M | Sell |
184,291
-6,035
| -3% | -$1.17M | 0.05% | 339 |
|
|
2021
Q1 | $25.2M | Buy |
190,326
+140
| +0.1% | +$22.1K | 0.03% | 475 |
|
|
2020
Q4 | $32.9M | Buy |
190,186
+14,828
| +8% | +$2.03M | 0.05% | 356 |
|
|
2020
Q3 | $19.5M | Buy |
175,358
+4,233
| +2% | +$338K | 0.03% | 467 |
|
|
2020
Q2 | $10.1M | Buy |
171,125
+39,086
| +30% | +$2.57M | 0.02% | 657 |
|
|
2020
Q1 | $8.89M | Sell |
132,039
-654
| -0.5% | -$51.7K | 0.02% | 594 |
|
|
2019
Q4 | $11.2M | Sell |
132,693
-2,680
| -2% | -$216K | 0.02% | 645 |
|
|
2019
Q3 | $10.1M | Buy |
135,373
+4,900
| +4% | +$392K | 0.02% | 656 |
|
|
2019
Q2 | $8.25M | Buy |
130,473
+17,791
| +16% | +$901K | 0.02% | 741 |
|
|
2019
Q1 | $5.43M | Sell |
112,682
-2,585
| -2% | -$124K | 0.01% | 925 |
|
|
2018
Q4 | $3.86M | Buy |
115,267
+2,677
| +2% | +$97.9K | 0.01% | 1061 |
|
|
2018
Q3 | $5.9M | Buy |
112,590
+2,633
| +2% | +$105K | 0.01% | 918 |
|
|
2018
Q2 | $3.44M | Buy |
109,957
+20,784
| +23% | +$578K | 0.01% | 1248 |
|
|
2018
Q1 | $1.94M | Sell |
89,173
-1,873
| -2% | -$40.3K | ﹤0.01% | 1544 |
|
|
2017
Q4 | $1.84M | Sell |
91,046
-1,423
| -2% | -$27.4K | ﹤0.01% | 1626 |
|
|
2017
Q3 | $1.84M | Sell |
92,469
-9,840
| -10% | -$193K | ﹤0.01% | 1630 |
|
|
2017
Q2 | $1.77M | Buy |
102,309
+2,600
| +3% | +$33.6K | ﹤0.01% | 1675 |
|
|
2017
Q1 | $808K | Sell |
99,709
-4,500
| -4% | -$32.5K | ﹤0.01% | 2203 |
|
|
2016
Q4 | $818K | Sell |
104,209
-2,900
| -3% | -$23.3K | ﹤0.01% | 2234 |
|
|
2016
Q3 | $915K | Buy |
107,109
+900
| +0.8% | +$8.21K | ﹤0.01% | 2138 |
|
|
2016
Q2 | $1.24M | Buy |
106,209
+88,030
| +484% | +$1.1M | ﹤0.01% | 1909 |
|
|
2016
Q1 | $263K | Buy |
18,179
+2,529
| +16% | +$36.3K | ﹤0.01% | 2721 |
|
|
2015
Q4 | $350K | Buy |
+15,650
| New | +$374K | ﹤0.01% | 2633 |
|
Other funds holding NVCR
SCM
VPM
VCM
QCM
California State Teachers Retirement System (CalSTRS)'s NVCR Position: Q1 2026 in Review
California State Teachers Retirement System (CalSTRS) increased its NovoCure (NVCR) stake by 44% in Q1 2026, buying an estimated $540K and bringing the position to 142,561 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1660.
California State Teachers Retirement System (CalSTRS) first reported a position in NVCR in Q4 2015 and has held it in 42 quarters since. The position peaked at $40.9M in Q2 2021. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) held 142,561 shares of NovoCure worth $1.55M as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) bought 43,257 NovoCure shares in Q1 2026, an estimated $540K.
- NovoCure made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1660 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in NovoCure in Q4 2015 and has held it in 42 quarters since.
- California State Teachers Retirement System (CalSTRS)'s NovoCure position peaked at $40.9M in Q2 2021.
- 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.